Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Muscle Nerve. Author manuscript; available in PMC 2010 March 30.
Published in final edited form as:
PMCID: PMC2847417



Amyotrophic lateral sclerosis (ALS) remains a clinical diagnosis without definable biomarkers. The pathomechanism of motor neuron degeneration in ALS has yet to be elucidated. Here we present a case of limb-onset ALS, with autopsy findings of Bunina bodies and skein-like inclusions, as well as sarcoid granulomas predominating among motor neurons. The targeting of the motor neurons by the sarcoid inflammation raises questions regarding the role of cellular immunity in the pathomechanisms for ALS.

Keywords: amyotrophic lateral sclerosis, sarcoidosis, autopsy, ubiquitin, TDP-43

To our knowledge, there have been four case reports of clinical amyotrophic lateral sclerosis (ALS) and sarcoidosis.2,7,9,11 Only one of them included an autopsy study that confirmed the coexistence of both diseases, although the sarcoidosis did not have pathological involvement of the nervous system.11 Here we present a case of a 61-year-old woman with autopsy-proven ALS who had a striking sarcoid-granulomatous reaction chiefly at sites of motor neurons in the brain and spinal cord.


A 61-year-old woman was evaluated in our center for progressive extremity weakness and gait difficulty. She had a 5-year history of urinary urgency with intermittent incontinence, and a few-month history of paresthesia in her arms. The incontinence worsened in the months prior to our evaluation, possibly due to gait difficulty. Her paresthesia resolved spontaneously. She denied any other central nervous system symptoms. Examination revealed normal mental status, cranial nerves, sensory systems, and coordination. Motor system examination revealed no fasciculations, but muscle tone was increased. Muscle atrophy was present in both the deltoid and intrinsic hand muscles. Formal power testing showed diffuse weakness in the distal arm muscles with strength less than anti-gravity, and moderate weakness in the proximal arm muscles with strength against resistance. Strength in the legs was full except for hip and knee flexion, which were against resistance. There was pathological hyperreflexia, including a brisk jaw jerk, bilateral Hoffman signs, and ankle clonus. The plantar responses are flexor.

Routine laboratory tests were normal, including complete blood cell counts, routine chemistry, sedimentation rate, rheumatoid factor, and anti-SSA/ SSB (extractable nuclear antigens) antibodies. The antinuclear antibodies (ANA) titer was 1:80 (reference <01:40), speckled pattern. Angiotensin-converting enzyme (ACE) was 69 (reference 8 -52). Chest x-ray from 3 months earlier was normal without hilar lymphadenopathy (LAD). Magnetic resonance imaging (MRI) of the brain and cervical spine was unre-markable. Electromyogram (EMG) and nerve conduction studies obtained 8 months prior to our evaluation showed acute and chronic denervation in left arm myotomes and absent F waves in the ulnar nerve, which was initially thought to suggest left brachial plexopathy. A second EMG obtained 1 month prior to our evaluation showed diffuse fibrillation and fasciculation potentials and chronic motor unit potential reinnervation with reduced motor unit recruitment in four extremities and fasciculation potentials in the thoracic paraspinal muscles. The progression of EMG findings along with the clinical examination suggested that she had probable ALS by El Escorial criteria.3

Because of some atypical features for ALS in her presentation, including transient paresthesia and urinary urgency and incontinence, we obtained visual-and somatosensory-evoked potentials and they were normal. Magnetic resonance spectroscopy showed reduced N-acetylaspartate to creatine (NAA/Cr) ratio in bilateral motor strips in the cortex (right motor strip NAA/Cr = 1.52, left motor strip NAA/Cr = 1.93; lower limit normal = 2.5).8 Transcranial magnetic stimulation showed prolonged central conduction times of both arms and legs, as well as prolonged peripheral conduction times in the left arm and both legs. Repeat EMG showed active and chronic denervation in three limbs and thoracic paraspinals, sparing the tongue. Cerebrospinal fluid (CSF) analysis showed 3 white blood cells and 0 red blood cells with normal glucose and protein. The CSF was not tested for IgG index and oligoclonal bands. The patient was started on Riluzole and Baclofen. In subsequent months, she developed increasing spasticity, limb dysfunction, and bulbar palsy along with pseudobulbar affect. Due to her progressive diaphragm insufficiency, the forced vital capacity dropped from 100% at initial evaluation to 76% of predicted value 2 months later and to 49% at 5-month follow-up. She was transferred to hospice care and died 19 months from the onset of limb weakness.

Autopsy determined that the patient most likely died from aspiration pneumonia with mixed flora found in the left lung and a few Klebsiella pneumoniae in the right lung cultures. Sarcoid-type noncaseating granulomas were present in both lungs and hilar lymph nodes. Neuropathology of the brain and spinal cord confirmed the clinical diagnosis of ALS. The nervous system demonstrated degeneration of the pyramidal tracts (Fig. 1A) with more severe abnormality in the spinal cord than in the brainstem and internal capsule, as highlighted by CD68-stained microglia and macrophages. There was also loss of motor neurons and astrocytosis in the motor nuclei of cranial nerves VII and XII with sparing of the oculomotor nucleus. Neuronal loss was present in the ventral horns and was most severe at cervical levels. Sparse surviving motor neurons contained intracytoplasmic Bunina bodies and skein-like inclusions which expressed ubiquitin (Fig. 1B) and TDP-43, strongly supporting the diagnosis of ALS. However, to our surprise, small granulomas were found chiefly at sites of motor neurons, including the precentral gyrus, motor nuclei of cranial nerves (V, VII. and XII), and ventral horns (Fig. 1C). Most granulomas in the precentral gyrus were located around or adjacent to venules, but these lesions were not clearly related to blood vessels in brainstem, spinal cord, or elsewhere. A few granulomas were also found in the putamen and red nucleus, and they were seen rarely in the caudate nucleus, globus pallidus, thalamus, substantia nigra, and medullary tegmentum. Uncharacteristically, the granulomatous lesions were observed rarely in their typical location for neurosarcoidosis, such as the leptomeninges and base of the telencephalon. Skeletal muscle was severely involved and included large tumor-like granulomas (Fig. 1D).

Spinal cord and skeletal muscle in autopsy of a patient with ALS and sarcoidosis. (A) The cervical level of the spinal cord shows prominent infiltration of the region of the crossed and uncrossed pyramidal tracts (arrows) by microglia and macrophages. ...


To date, ALS remains a clinical diagnosis of exclusion because it has no identifiable biomarkers. Our patient presented with weakness that appeared to spread from upper to lower extremities, and then involved her oropharyngeal muscles. The disease eventually affected the diaphragm, with evidence for both upper and lower motor neuron dysfunction. Her presentation and clinical course was rather characteristic of ALS, and the diagnosis was confirmed by the neuropathological findings with pyramidal tract degeneration and characteristic motor neuron involvement including Bunina bodies and skein-like inclusions. However, the autopsy finding of sarcoid granulomas in the lungs, lymph nodes, skeletal muscle, and the nervous system was not anticipated. Clinically, the patient did not have the typical features of systemic sarcoidosis, such as skin plaques, facial lupus pernio, anterior uveitis, or hilar lymphadenopathy. Although prior evaluation revealed a slight elevation of ACE levels, this is neither specific nor diagnostic of sarcoidosis.5,6 Interestingly, neurosarcoidosis represents about 5%-15% of all sarcoidosis cases, and the diagnosis is made antemortem only 50% of the time.10 Given the clinical and electrodiagnostic evidence for motor neuron dysfunction in our patient, we did not further investigate the possibility of neurosarcoidosis, as that is also a diagnosis of exclusion.

There have been two case reports of clinical “bulbar ALS,” in whom subsequent studies suggested the patients had sarcoidosis.2,9 One of the patients had improved bulbar and limb function in response to prednisone treatment after a lymph node biopsy indicated sarcoidosis.9 The “bulbar ALS” patient was later diagnosed as “sarcoid brainstem encephalitis” after autopsy.2 Pathologically, this case differs from ours, as the brain and spinal cord did not have histopathological evidence of ALS, such as motor neuron loss, intracytoplasmic Bunina bodies, or ubiquinated inclusions (pathologist Martin Lammens, personal communication) (Table 1). Both cases highlight the significant overlap in the clinical presentation of neurosarcoidosis and bulbar ALS, and they remind clinicians of the need to maintain a high clinical suspicion for this form of brainstem encephalitis when evaluating patients for bulbar ALS.

Table 1
Data from four patients with sarcoidosis and ALS or bulbar ALS-like syndrome

There have been two reported cases of ALS and sarcoidosis that coexist in the same patient.7,11 One patient with autopsy-proven ALS exhibited sarcoid granulomas in the lungs and muscles with sparing of the meninges, brain, and spinal cord. The other patient had clinical resolution of hilar LAD in response to prednisone treatment, but the motor disorder progressed to a state of severe, diffuse weakness in the subsequent 10 months. No autopsy was performed to determine whether sarcoidosis involved the central nervous system (Table 1). Our patient appears to be the first case of ALS that shows coexisting neurosarcoidosis. Moreover, sarcoid granulomas targeted chiefly the anterior horns, brainstem motor nuclei, and motor cortex.

The etiology of sarcoidosis is not known, but the disorder is thought to result from an immunological response to poorly soluble or insoluble antigen. Epidemiological studies suggest that the disease is likely a consequence of a genetic susceptibility of patients in combination with exposure to an environmental agent.5 Although the disorder shows a predilection for lymph nodes, lungs, skin, eyes, and skeletal muscle, it only rarely exhibits tissue specificity as exemplified in the nervous system in this ALS case. Rarely, sarcoid granulomatous lesions appear in skin tattoos or scars of systemic sarcoidosis,1,4,12 and they sometimes demonstrate exquisite specificity of the inflammatory response to one pigment of a multicolor tattoo. This rare granulomatous manifestation of sarcoidosis in tattoos suggests possible shared pathomechanisms with this ALS patient. It is possible that the motor neuron degeneration in this case resembled tattoos or scars and triggered a local granulomatous inflammatory reaction to an insoluble material in the setting of sarcoidosis. In addition, cytokines or other factors arising in the inflammatory cells may have contributed to the degeneration of motor neurons. Clearly, the molecular basis of this interesting phenomenon requires a better understanding of the pathomechanisms of both ALS and sarcoidosis.

Our experience suggests that ALS is a clinical syndrome and that autopsy study is still of paramount importance for confirmation of the diagnosis and furthering understanding of the disease pathology. The rate of autopsy has gradually declined in recent years. However, clinicians must confirm their diagnosis with autopsy even when we are quite confident about the clinical diagnosis.


This study was supported by MDA Wings Over Wall Street (HM). The authors thank Dr. Alexander G. Khandji for reviewing the neuroimages and the patients and family for their support of autopsy-based research in amyotrophic lateral sclerosis. We express special gratitude to the patient's three daughters, Dominique Mahal, Angelique Mahal, and Dr. Jacqueline Mahal, MD, for arranging and providing support for this autopsy study since it fulfills the mother's final desire as a way to contribute to science. They also have given permission for the publication of this report.


angiotensin-converting enzyme
amyotrophic lateral sclerosis
anti-nuclear antibodies
cluster of differentiation
cerebrospinal fluid
extractable nuclear antigens


1. Ali SM, Gilliam AC, Brodell RT. Sarcoidosis appearing in a tattoo. J Cutan Med Surg. 2008;12:43–48. [PubMed]
2. Bos MM, Overeem S, van Engelen BG, Scheffer H, van den Elzen C, Ter Laak H, et al. A case of neuromuscular mimicry. Neuromuscul Disord. 2006;16:510–513. [PubMed]
3. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–299. [PubMed]
4. Collins P, Evans AT, Gray W, Levison DA. Pulmonary sarcoidosis presenting as a granulomatous tattoo reaction. Br J Dermatol. 1994;130:658–662. [PubMed]
5. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004;3:397–407. [PubMed]
6. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–2165. [PubMed]
7. Karacostas D, Parissis D, Michailidou B, Mavromatis I, Ropper AH. Amyotrophic lateral sclerosis with sarcoidosis. Amyotroph Lateral Scler. 2007;8:191–192. [PubMed]
8. Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, Del Bene ML, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS) Neurology. 2004;62:1753–1757. [PubMed]
9. Koide T, Kanazawa M, Shinbo J, Urayama K, Yagi N, Tsuchida S, et al. A patient with sarcoidosis needed differential diagnosis from motor neuron disease. Rinsho Shinkeigaku. 2005;45:485–489. [PubMed]
10. Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol. 2001;248:363–372. [PubMed]
11. Saiki S, Yoshioka A, Yamaya Y, Hirose G. Amyotrophic lateral sclerosis associated with sarcoidosis. Intern Med. 2001;40:822–825. [PubMed]
12. Sowden JM, Cartwright PH, Smith AG, Hiley C, Slater DN. Sarcoidosis presenting with a granulomatous reaction confined to red tattoos. Clin Exp Dermatol. 1992;17:446–448. [PubMed]